Search Results - "TRUDEL SUZANNE" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial

A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial

by Hay, Annette E., Trudel, Suzanne, Bahlis, Nizar J., White, Darrell, Sabry, Waleed, Belch, Andrew, Reiman, Tony J., Roy, Jean, Shustik, Chaim, Kovacs, Michael J., Sussman, Jonathan, Reece, Donna Ellen, Lacy, Martha, Meyer, Ralph M., Shepherd, Lois E., Whelan, Kate, Zhu, Liting, Chapman, Judy-Anne W., Stewart, A. Keith
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

$Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple Myeloma (MM)$

Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple Myeloma (MM)

by Chen, Christine I., Gutierrez, Martin, Siegel, David S., Richter, Joshua R., Wagner-Johnston, Nina, Hofmeister, Craig C, Berdeja, Jesus G., Gabrail, Nashat, Baz, Rachid, Mau-Sorensen, Morten, Trudel, Suzanne, Tiedemann, Rodger E., Kukreti, Vishal, Areethamsirikul, Nuchanan, Azmi, Asfar, Kashyap, Trinayan, Landesman, Yosef, Marshall, Tracey, McCartney, John, Saint-Martin, Jean-Richard, Norori, Sasha, Savona, Michael R, Rashal, Tami, Carlson, Robert, Mirza, Mansoor R, Shacham, Sharon, Kauffman, Michael, Reece, Donna E
Published in Blood (06.12.2014)

Get full text

Journal Article

Abstract 5448: The tricyclic anti-depressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases

Abstract 5448: The tricyclic anti-depressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases

by Mao, Xinliang, Wang, Wenjie, Cao, Biyin, Li, Zhihua, Hurren, Rose, Trudel, Suzanne, Schimmer, Aaron D.
Published in Cancer research (Chicago, Ill.) (15.04.2010)

Get full text

Journal Article

A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin

A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin

by Mao, Xinliang, Stewart, A. Keith, Hurren, Rose, Datti, Alessandro, Zhu, Xuegong, Zhu, Yuanxiao, Shi, Changxin, Lee, Kyle, Tiedemann, Rodger, Eberhard, Yanina, Trudel, Suzanne, Liang, Shengben, Corey, Seth J., Gillis, Lisa C., Barber, Dwayne L., Wrana, Jeffery L., Ezzat, Shereen, Schimmer, Aaron D.
Published in Blood (01.12.2007)

Get full text

Journal Article

The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenström Macroglobulinemia

The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenström Macroglobulinemia

by Croucher, Danielle C, Jimenez-Zepeda, Victor H, Li, Zhi Hua, Wei, Ellen, Page, Brent DG, Turkson, James, Gunning, Patrick T, Trudel, Suzanne
Published in Blood (18.11.2011)

Get full text

Journal Article

The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenström Macroglobulinemia

The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenström Macroglobulinemia

by Croucher, Danielle C, Jimenez-Zepeda, Victor H, Li, Zhi Hua, Wei, Ellen, Page, Brent DG, Turkson, James, Gunning, Patrick T, Trudel, Suzanne
Published in Blood (18.11.2011)

Get full text

Journal Article

Central Nervous System (CNS) Involvement with Multiple Myeloma (MM) – Longterm Survival Can Be Achieved with Radiation, Intrathecal (IT) Chemotherapy, and Immunomodulatory Agents (IMiDs)

Central Nervous System (CNS) Involvement with Multiple Myeloma (MM) – Longterm Survival Can Be Achieved with Radiation, Intrathecal (IT) Chemotherapy, and Immunomodulatory Agents (IMiDs)

by Chen, Christine, Rabea, Ahmed M., Masih-Khan, Esther, Chu, Chia-Min, Kukreti, Vishal, Trudel, Suzanne, Tiedemann, Rodger E., Reece, Donna E.
Published in Blood (18.11.2011)

Get full text

Journal Article

$A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma$

A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

by Trudel, Suzanne, Bergsagel, P. Leif, Singhal, Seema, Niesvizky, Ruben, Comenzo, Raymond L., Bensinger, William I., Lebovic, Daniel, Choi, YounJeong, Lu, Dan, French, Dorothy, Penuel, Elicia, Ho, William, Stewart, Keith
Published in Blood (16.11.2012)

Get full text

Journal Article

Light Chain Deposition Disease: Impact of Stem Cell Tranplant on Hematological Response Achievement

Light Chain Deposition Disease: Impact of Stem Cell Tranplant on Hematological Response Achievement

by Jimenez-Zepeda, Victor H, Franke, Norman, Winter, Andrew, Reece, Donna E., Trudel, Suzanne, Chen, Christine, Rabea, Ahmed M., Kukreti, Vishal
Published in Blood (19.11.2010)

Get full text

Journal Article

Cyproheptadine displays preclinical activity in myeloma and leukemia

Cyproheptadine displays preclinical activity in myeloma and leukemia

by Mao, Xinliang, Liang, Sheng-ben, Hurren, Rose, Gronda, Marcela, Chow, Sue, Xu, G. Wei, Wang, Xiaoming, Zavareh, Reza Beheshti, Jamal, Nazir, Messner, Hans, Hedley, David W., Datti, Alessandro, Wrana, Jeff L., Zhu, Yuanxiao, Shi, Chang-xin, Lee, Kyle, Tiedemann, Rodger, Trudel, Suzanne, Stewart, A. Keith, Schimmer, Aaron D.
Published in Blood (01.08.2008)

Get full text

Journal Article

High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)

High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)

by van Beers, Erik H, Van Vliet, Martin H., Anderson, Kenneth C., Chari, Ajai, Jagannath, Sundar, Jakubowiak, Andrzej, Kumar, Shaji K, Lebovic, Daniel, Levy, Joan, Lonial, Sagar, Reece, Donna E, Richardson, Paul G., Siegel, David S, Stewart, Keith, Trudel, Suzanne, Vij, Ravi, Zimmerman, Todd M., Fonseca, Rafael
Published in Blood (15.11.2013)

Get full text

Journal Article

FV-162 Is a Novel Orally Bioavailable Proteasome Inhibitor With Improved Pharmacokinetics That Displays Preclinical Efficacy In Vitro and In Vivo

FV-162 Is a Novel Orally Bioavailable Proteasome Inhibitor With Improved Pharmacokinetics That Displays Preclinical Efficacy In Vitro and In Vivo

by Wang, Zezhou, Dove, Peter, Wang, Xiaoming, Goard, Carolyn A., Li, Zhihua, Nachman, Alex, Oh, Yoonsun Jenny, Hurren, Rose, Ruschak, Amy, Climie, Shane, O'Neill, David, Press, Barry, Griffin, Carly, Undzys, Elijus, Aman, Ahmed, Al-awar, Rima, Kay, Lewis, Trudel, Suzanne, Slassi, Malik, Schimmer, Aaron
Published in Blood (15.11.2013)

Get full text

Journal Article

$Novel AKT Inhibitor Afuresertib In Combination With Bortezomib and Dexamethasone Demonstrates Favorable Safety Profile and Significant Clinical Activity In Patients With Relapsed/Refractory Multiple Myeloma$

Novel AKT Inhibitor Afuresertib In Combination With Bortezomib and Dexamethasone Demonstrates Favorable Safety Profile and Significant Clinical Activity In Patients With Relapsed/Refractory Multiple Myeloma

by Voorhees, Peter M, Spencer, Andrew, Sutherland, Heather J., O'Dwyer, Michael E, Huang, Shang-Yi, Stewart, Keith, Chari, Ajai, Rosenzwieg, Michael, Nooka, Ajay K., Rosenbaum, Cara A, Hofmeister, Craig C, Smith, Deborah A, Antal, Joyce M, Santiago-Walker, Ademi, Gauvin, Jennifer, Opalinska, Joanna B, Trudel, Suzanne
Published in Blood (15.11.2013)

Get full text

Journal Article

$Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom's Macroglobulinemia (WM)$

Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom's Macroglobulinemia (WM)

by Chen, Christine I., Gutierrez, Martin, de Nully Brown, Peter, Gabrail, Nashat, Baz, Rachid, Reece, Donna E., Savona, Michael, Trudel, Suzanne, Siegel, David S., Mau-Sorensen, Morten, Kuruvilla, John, Byrd, John C., Shacham, Sharon, Rashal, Tami, Yau, Cindy YF, McCauley, Dilara, Saint-Martin, Jean-Richard, McCartney, John, Landesman, Yosef, Klebanov, Boris, Pond, Greg, Oza, Amit M., Kauffman, Michael, Mirza, Mansoor R
Published in Blood (15.11.2013)

Get full text

Journal Article

$Sequencing Novel Agents in Relapsed/Refractory Multiple Myeloma: Use of Bortezomib-Based Therapy After Lenalidomide + Dexamethasone$

Sequencing Novel Agents in Relapsed/Refractory Multiple Myeloma: Use of Bortezomib-Based Therapy After Lenalidomide + Dexamethasone

by Reece, Donna E., Trieu, Young, Chen, Christine, Kukreti, Vishal, Xu, Wei, Anglin, Peter, Trudel, Suzanne
Published in Blood (20.11.2009)

Get full text

Journal Article

Low Risk of Reactivation of Hepatitis B and Hepatic Injury in Multiple Myeloma (MM) Patients (pts) Undergoing Autologous Stem Cell Transplant (ASCT)

Low Risk of Reactivation of Hepatitis B and Hepatic Injury in Multiple Myeloma (MM) Patients (pts) Undergoing Autologous Stem Cell Transplant (ASCT)

by Chen, Christine, Trieu, Young, Xu, Wei, Trudel, Suzanne, Kukreti, Vishal, Anglin, Peter, Reece, Donna E.
Published in Blood (20.11.2009)

Get full text

Journal Article

Longterm Survival (≥10 years) in Multiple Myeloma (MM) Is Associated with Longer Duration of Therapy and Improved Quality of Response to Novel agents

Longterm Survival (≥10 years) in Multiple Myeloma (MM) Is Associated with Longer Duration of Therapy and Improved Quality of Response to Novel agents

by Noroozi, Nastaran, Reece, Donna E., Trudel, Suzanne, Kukreti, Vishal, Anglin, Peter, Fernandes, Kimberly, Chen, Christine
Published in Blood (20.11.2009)

Get full text

Journal Article

Rapidity and Quality of Response to Steroid-Based Induction Therapy, Without the Addition of Novel Agents, Does Not Affect Post Transplant Outcomes in Multiple Myeloma

Rapidity and Quality of Response to Steroid-Based Induction Therapy, Without the Addition of Novel Agents, Does Not Affect Post Transplant Outcomes in Multiple Myeloma

by Prica, Anca, Trieu, Young, Xu, Wei, Reece, Donna E, Trudel, Suzanne, Kukreti, Vishal, Chen, Christine
Published in Clinical lymphoma, myeloma and leukemia (01.02.2013)

Get full text

Journal Article

Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma

Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma

by Chang, Hong, Stewart, A. Keith, Qi, Xiao Ying, Li, Zhi Hua, Yi, Qi Long, Trudel, Suzanne
Published in Blood (01.07.2005)

Get full text

Journal Article

Abstract A201: The potent STAT3/5 inhibitor, BP-1–102, demonstrates significant antitumor activity against Waldenstrom macroglobulinemia

Abstract A201: The potent STAT3/5 inhibitor, BP-1–102, demonstrates significant antitumor activity against Waldenstrom macroglobulinemia

by Croucher, Danielle C., Jimenez-Zepeda, Victor H., Page, Brent DG, Li, Zhi Hua, Wei, Ellen, Turkson, James, Gunning, Patrick T., Trudel, Suzanne
Published in Molecular cancer therapeutics (12.11.2011)

Get full text

Journal Article

[1]
Prev
8
9
10
11
12
13
14
15
16
17
18
Next
[19]